VAXXEL – Vaxxel raises EUR 1.2 million to support the development of its bivalent intranasal vaccine candidate against bronchiolitis and viral pneumonia – 03/18/2022 – 08:00

Press release Lyon (FR) – March 18, 2022, 8:00 am CET Vaxxel, a French start-up that develops vaccines against viral respiratory infections, announces a fundraising … Read more